HYBRID EVENT: Join us in person in Singapore or attend virtually from anywhere.

3rd Edition of International Cancer & Immuno-Oncology Conference

March 15-17, 2027 | Singapore
March 15-17, 2027 | Singapore

Cervical Cancer

Cervical Cancer

In the realm of cancer research, cervical cancer holds a significant place due to its preventable nature and the potential for early detection. With advancements in screening techniques like Pap smears and HPV testing, there's been a notable decline in cervical cancer cases in many parts of the world. Moreover, the development of HPV vaccines has emerged as a groundbreaking preventive measure against the strains of human papillomavirus responsible for the majority of cervical cancer cases. Cutting-edge research continues to explore novel treatment modalities, including targeted therapies and immunotherapies, offering hope for improved outcomes and quality of life for patients. By integrating innovative approaches to prevention, screening, and treatment, the fight against cervical cancer strides forward, promising a future where this disease is not just treatable, but preventable.

Committee Members
Committee Member - Michael Thompson

Michael Thompson

University of Toronto, Canada
Committee Member - Pietro Salvatori

Pietro Salvatori

Formerly, Humanitas San Pio X Hospital, Italy
Committee Member - Rajvir Dahiya

Rajvir Dahiya

University of California San Francisco, United States

Submit your abstract Today

YouTube
WhatsAppWhatsApp